StockData
Palvella Therapeutics, Inc. logo

Palvella Therapeutics, Inc. (PVLA) stock

PVLANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$146.58+2.23 (+1.54%)

Close on Nov 18, 2026Market cap $2.11BP/E –Yield –

Palvella Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Palvella Therapeutics

Palvella Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Palvella Therapeutics figures

See a number that looks wrong?